The effects of neoadjuvant zoledronic acid in breast cancer patients: A meta-analysis of randomized controlled trials
Author:
Funder
Wu Jieping Medical Foundation
Publisher
Elsevier BV
Subject
Surgery
Reference25 articles.
1. Exploring the anti-tumour activity of bisphosphonates in early breast cancer;Winter;Cancer Treat Rev,2008
2. Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer;Ottewell;J Natl Cancer Inst,2008
3. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial;Coleman;Lancet Oncol,2014
4. Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12;Gnant;Ann Oncol Ann Oncol,2015
5. Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer:HOBOE phase 3 randomised trial;Perrone;Clinical Trial Eur J Cancer,2019
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Significance of zoledronic acid in the adjuvant therapy in patients with breast cancer;Polish Journal of Public Health;2024-07-31
2. Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer;Asian Journal of Surgery;2024-07
3. Effects of zoledronic acid and exemestane combination therapy on immune function, sex hormones, bone markers, and clinical efficacy in hormone receptor-positive breast cancer patients;European Journal of Gynaecological Oncology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3